Wealthedge Investment Advisors LLC Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Wealthedge Investment Advisors LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,171 shares of the healthcare conglomerate's stock, valued at approximately $592,000.

Several other large investors have also bought and sold shares of UNH. NewSquare Capital LLC bought a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group during the 4th quarter valued at approximately $26,000. Hurley Capital LLC bought a new stake in UnitedHealth Group in the fourth quarter worth $28,000. Aster Capital Management DIFC Ltd bought a new position in shares of UnitedHealth Group during the fourth quarter valued at $30,000. Finally, Promus Capital LLC bought a new position in UnitedHealth Group in the 4th quarter worth about $32,000. 87.86% of the stock is owned by institutional investors.

Analysts Set New Price Targets

UNH has been the topic of several analyst reports. Robert W. Baird dropped their target price on shares of UnitedHealth Group from $510.00 to $356.00 and set an "outperform" rating on the stock in a research note on Wednesday, May 14th. Bank of America downgraded UnitedHealth Group from a "buy" rating to a "neutral" rating and cut their target price for the company from $560.00 to $350.00 in a research note on Wednesday, May 14th. TD Securities reaffirmed a "hold" rating and set a $308.00 price target (down from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Morgan Stanley decreased their target price on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. Finally, Mizuho reduced their price target on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a research note on Friday, May 16th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $441.87.

UnitedHealth Group Stock Performance

NYSE UNH traded up $2.91 on Friday, reaching $301.08. 16,235,937 shares of the stock were exchanged, compared to its average volume of 6,781,164. The firm has a market capitalization of $273.12 billion, a PE ratio of 19.42, a PEG ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The company's 50-day simple moving average is $435.12 and its two-hundred day simple moving average is $496.39. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the prior year, the business earned $6.91 earnings per share. Analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Kristen Gil bought 3,700 shares of UnitedHealth Group stock in a transaction dated Thursday, May 15th. The shares were purchased at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the acquisition, the director now directly owns 3,818 shares in the company, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, Director Timothy Patrick Flynn acquired 1,533 shares of UnitedHealth Group stock in a transaction on Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the purchase, the director now directly owns 6,033 shares of the company's stock, valued at $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 109,408 shares of company stock valued at $31,607,768. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.